{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:00:22Z","timestamp":1794747622542,"version":"4.9.1"},"reference-count":44,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Lilly, USA LLC","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Boehringer Ingelheim Pharmaceuticals, Inc.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/05kffp613","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,10,14]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe screening programmes for early chronic kidney disease (CKD) in the USA and other English-speaking countries (Canada, Australia and UK) involving patients with diabetes or hypertension, in addition to high-risk racial or ethnic groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Embase and MEDLINE (both via Ovid) between 1 January 2018 and 17 October 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>CKD screening programmes in patients with diabetes and\/or hypertension in the targeted countries were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Publications meeting the review objectives and prespecified population, intervention, comparator, outcome and eligible study design types were identified. Full-text publications were assessed for quality by two independent reviewers. For randomised controlled trials, quality\/risk of bias (ROB) was assessed using version 2 of the Cochrane ROB tool for randomised trials; for observational longitudinal or prospective studies and non-randomised trials, quality\/ROB was assessed using the Newcastle-Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 5542 records identified from database searches, 21 studies were included. Of these, the majority (13 studies) screened patients with diabetes and\/or hypertension. Screening programmes were described in 16 studies; the remaining 5 reported CKD prevalence. Of 30\u2009643\u2009162 pooled participants, 6\u2009413\u2009466 (weighted mean: 21%) received complete screening for CKD (ie, evaluation of albumin-to-creatinine ratio plus estimated glomerular filtration rate). The weighted mean prevalences of any type of CKD testing in patients with diabetes or hypertension were 33% and 12%, respectively. For the pooled population of 24\u2009608 indigenous persons or underserved communities, the weighted mean prevalence of CKD screening was 91%. Weighted mean prevalences for any type of CKD testing were 22% (n=30 705 837) in primary care and 93% (n=26\u2009640) in community outreach settings. Follow-up testing was infrequent or not reported in most studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate a low prevalence of CKD screening of high-risk patients, particularly in primary care. Contrary to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, most high-risk patients studied received incomplete screening. Lack of adherence to KDIGO guidelines on CKD screening may result in delays in CKD diagnosis and missed opportunities for therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42023492433.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-099966","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:50:45Z","timestamp":1764057045000},"page":"e099966","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Screening programmes for early detection of chronic kidney disease in the USA and other English-speaking countries (Canada, Australia and UK): a systematic literature review"],"prefix":"10.1136","volume":"15","author":[{"given":"Pamela","family":"Kushner","sequence":"first","affiliation":[{"name":"University of California at Irvine Department of Family Medicine, Orange, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mende","sequence":"additional","affiliation":[{"name":"Division of Nephrology-Hypertension, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2026111421180849000_15.11.e099966.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.003"},{"key":"2026111421180849000_15.11.e099966.2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014070714"},{"key":"2026111421180849000_15.11.e099966.3","unstructured":"Centers for Disease Control and Prevention . Chronic kidney disease in the United States. 2023. Available: https:\/\/www.cdc.gov\/kidney-disease\/php\/data-research\/index.html [Accessed 16 Jul 2024]."},{"key":"2026111421180849000_15.11.e099966.4","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2023.10.018"},{"key":"2026111421180849000_15.11.e099966.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32064-5"},{"key":"2026111421180849000_15.11.e099966.6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030678","article-title":"Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts","volume":"13","author":"Mallamaci","year":"2024","journal-title":"J Clin Med"},{"key":"2026111421180849000_15.11.e099966.7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ajog.2023.10.008","article-title":"Adverse pregnancy outcomes and long-term risk of chronic kidney disease in women: national cohort and co-sibling study","volume":"230","author":"Crump","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"2026111421180849000_15.11.e099966.8","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13119"},{"key":"2026111421180849000_15.11.e099966.9","first-page":"385","article-title":"Screening: part 19 of a series on evaluation of scientific publications","volume":"109","author":"Spix","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"2026111421180849000_15.11.e099966.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.03.031"},{"key":"2026111421180849000_15.11.e099966.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.012"},{"key":"2026111421180849000_15.11.e099966.12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jval.2023.08.003","article-title":"Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review","volume":"27","author":"Rokhman","year":"2024","journal-title":"Value Health"},{"key":"2026111421180849000_15.11.e099966.13","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad137","article-title":"Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review","volume":"17","author":"Yeo","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026111421180849000_15.11.e099966.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.23.3101"},{"key":"2026111421180849000_15.11.e099966.15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ekir.2019.12.003","article-title":"Preventing CKD in Developed Countries","volume":"5","author":"Luyckx","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2026111421180849000_15.11.e099966.16","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S011"},{"key":"2026111421180849000_15.11.e099966.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"2026111421180849000_15.11.e099966.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2026111421180849000_15.11.e099966.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026111421180849000_15.11.e099966.20","unstructured":"Wells GA , Wells G , Shea B , et al . The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. Available: https:\/\/www.semanticscholar.org\/paper\/The-Newcastle-Ottawa-Scale-(NOS)-for-Assessing-the-Wells-Wells\/c293fb316b6176154c3fdbb8340a107d9c8c82bf [Accessed 12 Nov 2024]."},{"key":"2026111421180849000_15.11.e099966.21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ekir.2020.11.031","article-title":"A comprehensive quality assurance platform in Canada for national point-of-care chronic kidney disease screening: the Kidney Check Program","volume":"6","author":"Curtis","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026111421180849000_15.11.e099966.22","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1093\/pch\/pxy013","article-title":"Screening for kidney disease in Indigenous Canadian children: The FINISHED screen, triage and treat program","volume":"23","author":"Dart","year":"2018","journal-title":"Paediatr Child Health"},{"key":"2026111421180849000_15.11.e099966.23","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.210507"},{"key":"2026111421180849000_15.11.e099966.24","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201731"},{"key":"2026111421180849000_15.11.e099966.25","doi-asserted-by":"crossref","first-page":"2054358120922617","DOI":"10.1177\/2054358120922617","article-title":"Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients","volume":"7","author":"Papastergiou","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"2026111421180849000_15.11.e099966.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-024-02471-w","article-title":"Developing an integrated clinical decision support system for the early identification and management of kidney disease-building cross-sectoral partnerships","volume":"24","author":"Gorham","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026111421180849000_15.11.e099966.27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1071\/PY21248","article-title":"Challenges of conducting kidney health checks among patients at risk of chronic kidney disease and attending an urban Aboriginal and Torres Strait Islander primary healthcare service","volume":"28","author":"Lakhan","year":"2022","journal-title":"Aust J Prim Health"},{"key":"2026111421180849000_15.11.e099966.28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1071\/PY17156","article-title":"Screening and diagnosis of chronic kidney disease in people with type 2 diabetes attending Australian general practice","volume":"24","author":"Manski-Nankervis","year":"2018","journal-title":"Aust J Prim Health"},{"key":"2026111421180849000_15.11.e099966.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00876-0"},{"key":"2026111421180849000_15.11.e099966.30","doi-asserted-by":"crossref","DOI":"10.1016\/j.focus.2023.100133","article-title":"Albuminuria Screening in People With Type 2 Diabetes in a Managed Care Organization","volume":"2","author":"Keong","year":"2023","journal-title":"AJPM Focus"},{"key":"2026111421180849000_15.11.e099966.31","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05050419"},{"key":"2026111421180849000_15.11.e099966.32","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000532020"},{"key":"2026111421180849000_15.11.e099966.33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000495082","article-title":"Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project","volume":"48","author":"Burrows","year":"2018","journal-title":"Am J Nephrol"},{"key":"2026111421180849000_15.11.e099966.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.07.037"},{"key":"2026111421180849000_15.11.e099966.35","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1324-z"},{"key":"2026111421180849000_15.11.e099966.36","first-page":"475","article-title":"High prevalence and low awareness of albuminuria in the community setting in the KDSAP","volume":"5","author":"Zhuo","year":"2020","journal-title":"KI Rep"},{"key":"2026111421180849000_15.11.e099966.37","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0723"},{"key":"2026111421180849000_15.11.e099966.38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ckj\/sfz108","article-title":"Kidney Mentoring and Assessment Program for Students: a guide for engaging medical students in nephrology","volume":"12","author":"Bayliss","year":"2019","journal-title":"Clin Kidney J"},{"key":"2026111421180849000_15.11.e099966.39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.NPR.0000657316.97157.e4","article-title":"Screening for diabetic kidney disease in primary care: A quality improvement initiative","volume":"45","author":"Deem","year":"2020","journal-title":"Nurse Pract"},{"key":"2026111421180849000_15.11.e099966.40","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1136\/bmjoq-2021-001591","article-title":"Improving annual albuminuria testing for individuals with diabetes","volume":"11","author":"Kam","year":"2022","journal-title":"BMJ Open Qual"},{"key":"2026111421180849000_15.11.e099966.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1079-y","article-title":"The National Kidney Foundation of Illinois KidneyMobile: a mobile resource for community based screenings of chronic kidney disease and its risk factors","volume":"19","author":"Lederer","year":"2018","journal-title":"BMC Nephrol"},{"key":"2026111421180849000_15.11.e099966.42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000500706","article-title":"Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes","volume":"50","author":"Lee","year":"2019","journal-title":"Am J Nephrol"},{"key":"2026111421180849000_15.11.e099966.43","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11606-019-05353-4","article-title":"Translating CKD Research into Primary Care Practice: a Group-Randomized Study","volume":"35","author":"Litvin","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2026111421180849000_15.11.e099966.44","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.7326\/ANNALS-24-00549","article-title":"Shortfalls in Follow-up Albuminuria Quantification After an Abnormal Result on a Urine Protein Dipstick Test","volume":"177","author":"Xu","year":"2024","journal-title":"Ann Intern Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-099966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:21:26Z","timestamp":1794720086000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-099966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjopen-2025-099966"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-099966","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-099966.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}